Vivos Therapeutics, Inc. (VVOS) Capital expenditures 2019–2025
Vivos Therapeutics, Inc. (VVOS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.3MFY2025 · since FY2019: $175,599 → $2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.3M | +312.1% |
| FY2024 | $568,000 | -29.3% |
| FY2023 | $803,000 | -13.1% |
| FY2022 | $924,000 | -61.4% |
| FY2021 | $2.4M | +1896.7% |
| FY2020 | $120,000 | -31.7% |
| FY2019 | $175,599 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice